ADVERTISEMENT

PE firm Actis says invests $48 million in Symbiotec Pharmalab

Private equity firm Actis said on Tuesday it invested $48 million in Indian pharmaceuticals company Symbiotec Pharmalab Ltd for a significant stake.
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit